3 completed, 1 unknown. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
Follow Indapamide: new trials by email Literature Review of Indapamide trials Research Report on Indapamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet - Bioequivalence | Phase 1 | Unknown | Pharmtechnology LLC | 50 | 2023-06-24 | 2023-07-11 |
| A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers BR1015-1, BR1015-2, BR1015-1 + BR1015-2 - Hypertension | Phase 1 | Completed | Boryung Pharmaceutical Co., Ltd | 31 | 2021-08-16 | 2021-11-22 |
| Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets, TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets - Bioequivalence, Healthy Subjects | Phase 1 | Completed | Darnitsa Pharmaceutical Company | 52 | 2021-05-30 | 2022-07-22 |
| Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers PERINDOPRES® DUO 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets, Noliterax® 10 mg/2.5 mg 10 mg perindopril arginine / 2.5 mg indapamide film-coated tablets - Bioequivalence, Healthy Subjects | Phase 1 | Completed | Darnitsa Pharmaceutical Company | 42 | 2021-05-19 | 2022-07-19 |
Hypertension (1)
Darnitsa Pharmaceutical Company (2) · Boryung Pharmaceutical Co., Ltd (1) · Pharmtechnology LLC (1)
Jordan (2) · Russia (1) · South Korea (1)
An-Hye Kim, M.D. Ph.D (1) · Irina Rodyukova (1)